Meyka Pro banner
Cerenome, Inc.

Cerenome, Inc. (CNSY) Stock Overview

Explore Cerenome, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CNSYNASDAQ
HealthcareMedical - Pharmaceuticals
$3.84
$0.010(0.26%)
U.S. Market opens in 11h 45m

Cerenome, Inc. (CNSY)

Meyka AI Score

Z

Key Financials

Market Cap26.4M
P/E RatioN/A
EPS (TTM)$-7.19
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

CNSY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cerenome, Inc. (NASDAQ: CNSY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Cerenome, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CNSY on the NASDAQ shows an RSI of 100.00, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Cerenome, Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 26.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CNSY on the NASDAQ.

Price Performance (NASDAQ: CNSY)

1-Day Change
0.26%
5-Day Change
-6.11%
1-Month Change
-4.00%
3-Month Change
-5.19%
6-Month Change
-5.19%
Year-to-Date (YTD) Change
-5.19%
1-Year Change
-5.19%
3-Year Change
-5.19%
5-Year Change
-5.19%
All-Time (Max) Change
-5.19%

Contact Information

NaN
NaN, Houston, TX, NaN

Company Facts

280 Employees
IPO DateAug 3, 2026
CountryUS
Actively Trading

Frequently Asked Questions